Aberrant expression of functional baff-system receptors by malignant b-cell precursors impacts leukemia cell survival

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Maia, Sara ^a,d   Pelletier, Marc ^c   Ding, Jixin ^b   Hsu, Yen Ming ^c   Sallan, Stephen E ^a   Rao, Sambasiva P ^c,e   Nadler, Lee M ^a   Cardoso, Angelo A ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BIOGEN   (United States)

^d INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^e GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; B CELL ACTIVATING FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; TNFSF13B PROTEIN, HUMAN;

ARTICLE; B CELL LEUKEMIA; BONE MARROW CELL; CANCER PATIENT; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRE B LYMPHOCYTE; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PRECURSOR CELLS, B-LYMPHOID; PROTO-ONCOGENE PROTEINS C-AKT; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 79958152303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020787     Document Type: Article

References (52)

1. Bissell MJ, Radisky D, (2001) Putting tumours in context. Nat Rev Cancer 1: 46-54.
2. Bradstock KF, Gottlieb DJ, (1995) Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk Lymphoma 18: 1-16.
3. Campana D, Coustan-Smith E, Manabe A, Kumagai M, Murti KG, et al. (1996) Human B-cell progenitors and bone marrow microenvironment. Hum Cell 9: 317-322.
4. Mudry RE, Fortney JE, York T, Hall BM, Gibson LF, (2000) Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 96: 1926-1932.
5. Barata JT, Cardoso AA, Nadler LM, Boussiotis VA, (2001) Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1). Blood 98: 1524-1531.
6. Veiga JP, Costa LF, Sallan SE, Nadler LM, Cardoso AA, (2006) Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival. Exp Hematol 34: 610-621.
7. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, et al. (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189: 1747-1756.
8. Mackay F, Schneider P, (2009) Cracking the BAFF code. Nat Rev Immunol 9: 491-502.
9. Batten M, Groom J, Cachero TG, Qian F, Schneider P, et al. (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192: 1453-1466.
10. Rolink AG, Tschopp J, Schneider P, Melchers F, (2002) BAFF is a survival and maturation factor for mouse B cells. Eur J Immunol 32: 2004-2010.
11. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, et al. (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190: 1697-1710.
12. Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, et al. (2000) Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A 97: 3370-3375.
13. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, et al. (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263.
14. Hahne M, Kataoka T, Schroter M, Hofmann K, Irmler M, et al. (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188: 1185-1190.
15. Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, et al. (2000) BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med 192: 129-135.
16. Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, et al. (2000) Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 10: 785-788.
17. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, et al. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999.
18. Laabi Y, Gras MP, Brouet JC, Berger R, Larsen CJ, et al. (1994) The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res 22: 1147-1154.
19. von Bulow GU, Bram RJ, (1997) NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278: 138-141.
20. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, et al. (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293: 2108-2111.
21. Yan M, Brady JR, Chan B, Lee WP, Hsu B, et al. (2001) Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 11: 1547-1552.
22. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, et al. (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293: 2111-2114.
23. Xu S, Lam KP, (2001) B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol 21: 4067-4074.
24. Yan M, Wang H, Chan B, Roose-Girma M, Erickson S, et al. (2001) Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2: 638-643.
25. von Bulow GU, van Deursen JM, Bram RJ, (2001) Regulation of the T-independent humoral response by TACI. Immunity 14: 573-582.
26. Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, et al. (2000) TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med 192: 137-143.
27. Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, et al. (2000) Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol 1: 37-41.
28. Mackay F, Schneider P, Rennert P, Browning J, (2003) BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21: 231-264.
29. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, et al. (2002) DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3: 822-829.
30. Craxton A, Magaletti D, Ryan EJ, Clark EA, (2003) Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471.
31. Tangye SG, Bryant VL, Cuss AK, Good KL, (2006) BAFF, APRIL and human B cell disorders. Semin Immunol 18: 305-317.
32. Lopez-Fraga M, Fernandez R, Albar JP, Hahne M, (2001) Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2: 945-951.
33. Sipkins DA, Wei X, Wu JW, Runnels JM, Cote D, et al. (2005) In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435: 969-973.
34. Rennert P, Schneider P, Cachero TG, Thompson J, Trabach L, et al. (2000) A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med 192: 1677-1684.
35. Karpusas M, Cachero TG, Qian F, Boriack-Sjodin A, Mullen C, et al. (2002) Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. J Mol Biol 315: 1145-1154.
36. He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, et al. (2004) Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 172: 3268-3279.
37. Moreaux J, Legouffe E, Jourdan E, Quittet P, Reme T, et al. (2004) BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103: 3148-3157.
38. Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, et al. (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106: 1012-1020.
39. Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, et al. (1996) Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88: 41-48.
40. Cardoso AA, Seamon MJ, Afonso HM, Ghia P, Boussiotis VA, et al. (1997) Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood 90: 549-561.
41. Day ES, Cachero TG, Qian F, Sun Y, Wen D, et al. (2005) Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 44: 1919-1931.
42. Parameswaran R, Muschen M, Kim YM, Groffen J, Heisterkamp N, (2010) A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias. Cancer Res 70: 4346-4356.
43. Darce JR, Arendt BK, Wu X, Jelinek DF, (2007) Regulated expression of BAFF-binding receptors during human B cell differentiation. J Immunol 179: 7276-7286.
44. Smith SH, Cancro MP, (2003) Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J Immunol 170: 5820-5823.
45. Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, et al. (2007) TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 178: 7531-7539.
46. Xu LG, Shu HB, (2002) TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J Immunol 169: 6883-6889.
47. Reid GS, She K, Terrett L, Food MR, Trudeau JD, et al. (2005) CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response. Blood 105: 3641-3647.
48. Corthals SL, Wynne K, She K, Shimizu H, Curman D, et al. (2006) Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia. Br J Haematol 132: 452-458.
49. Moreaux J, Cremer FW, Reme T, Raab M, Mahtouk K, et al. (2005) The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106: 1021-1030.
50. Tai YT, Li XF, Breitkreutz I, Song W, Neri P, et al. (2006) Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res 66: 6675-6682.
51. Kimberley FC, Hahne M, Medema JP, (2009) "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival. J Cell Physiol 218: 1-8.
52. Costa LF, Balcells M, Edelman ER, Nadler LM, Cardoso AA, (2006) Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB. Blood 107: 285-292.